CD39 modulates IL-1 release from activated endothelial cells

Biochem Biophys Res Commun. 2000 Apr 2;270(1):272-8. doi: 10.1006/bbrc.2000.2410.

Abstract

The activation of endothelial cells (EC) and monocyte-macrophages (Mφ) by lipopolysaccharide (LPS) is considered an important element of the vascular injury observed in endotoxemia. Interleukin-1 (IL-1) beta release from Mφ in response to LPS, appears to be mediated by the autocrine/paracrine release of ATP via P2X7 receptor activation. In EC, similar nucleotide-mediated signaling pathways may be influenced by high levels of expression of CD39, the vascular nucleoside triphosphate diphosphohydrolase (NTPDase; ENTPD I). To determine whether CD39 modulates ATP-mediated release of IL-1 from EC, we stimulated human EC with LPS and measured levels of ATP secretion and IL-1 release. LPS triggered ATP secretion from EC that was soon followed by IL-1alpha release. Overexpression of CD39 following infection with recombinant CD39 adenoviral vectors (AdCD39) abrogated the initial phase of ATP secretion and inhibited IL-1alpha release; comparable results were obtained with soluble NTPDase. These data demonstrate that CD39/NTPDase modulates IL-1alpha release from LPS stimulated human EC.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphatases*
  • Adenosine Triphosphate / metabolism*
  • Adenosine Triphosphate / pharmacology
  • Antigens, CD / genetics
  • Antigens, CD / metabolism*
  • Apyrase / metabolism*
  • Endothelium, Vascular / immunology*
  • Endotoxemia / immunology
  • Humans
  • Interleukin-1 / metabolism*
  • Lipopolysaccharides / pharmacology
  • Recombinant Proteins / metabolism

Substances

  • Antigens, CD
  • Interleukin-1
  • Lipopolysaccharides
  • Recombinant Proteins
  • Adenosine Triphosphate
  • Adenosine Triphosphatases
  • Apyrase
  • CD39 antigen